Menu

BeyondSPX has rebranded as EveryTicker. We now operate at everyticker.com, reflecting our coverage across nearly all U.S. tickers. BeyondSPX has rebranded as EveryTicker.

Sensient Technologies Corporation (SXT)

$123.27
+24.03 (24.22%)
Get curated updates for this stock by email. We filter for the most important fundamentals-focused developments and send only the key news to your inbox.

Data provided by IEX. Delayed 15 minutes.

Company Profile

Price Chart

Loading chart...

At a glance

The single largest revenue opportunity in Sensient's 143-year history is materializing now: A $100 million synthetic color revenue base converting to natural at ~10:1 ratio creates a potential $1 billion revenue opportunity, with regulatory tailwinds (FDA Red 3 ban, West Virginia synthetic color ban, Walmart's (WMT) 2027 commitment) accelerating customer conversions that management describes as "very strong and building." * A 15-year supply chain moat creates durable competitive advantage: Since 2008, Sensient has invested in natural color capabilities including internal R&D, acquisitions, production facilities, and supplier development, building a botanical sourcing network that competitors cannot replicate quickly, making the company "generally regarded as a very good natural color company" with products "others do not have to the same level of precision and consistency." * 2026 is an investment year that sets up 2027-2028 profit inflection: Management expects mid to double-digit revenue growth but only mid-single-digit to high-single-digit EPS growth in 2026 as $150-170 million in capex (part of $225-250 million total 2025-2028) pressures margins, but this positions the company to capture the full conversion opportunity when synthetic products must exit store shelves by January 2028.

Agricultural Ingredients has reached its inflection point: After a challenging 2025 impacted by severe California rains, higher crop costs, and tariff disruptions, the renamed Sensient Agricultural Ingredients business is expected to deliver improved top line performance in 2026 with a reduction in crop costs starting mid-to-late Q4 2025, providing a second earnings driver.

Valuation at $87 reflects transformation premium but balance sheet supports execution: Trading at 27.5x earnings and 15.6x EBITDA with a 1.9% dividend yield, SXT commands a premium to some peers but maintains a conservative 2.3x net debt/EBITDA ratio and $400 million revolver capacity, providing financial flexibility for the multi-year conversion investment cycle.